Fujita N, Karabatsos N, Shope R E
Microbiol Immunol. 1978;22(6):315-23. doi: 10.1111/j.1348-0421.1978.tb00376.x.
Protamine treatment of type 1 dengue-infected mouse brain suspension resulted in precipitation of several viral specific activities. Complement-fixation activity was almost completely precipitated by protamine. The complement-fixation components recovered in the precipitate were comparable to a non-precipitated reference dengue 1 antigen in their homologous and heterologous reactions. Dengue hemagglutinin was also precipitated by the same treatment. The precipitated hemagglutinin was resolved into three components by buoyant density centrifugation, whose densities were 1.236, 1.215, and 1.178 g/ml, respectively. Three similar HA components were detected in non-protamine treated virus preparations. In both instances the highest-titered HA fraction possessed a buoyant density of 1.21--1.22 g/ml. These HA components were tested in the hemagglutination-inhibition reaction and were proved to be virus-specific. Cesium chloride density gradient centrifugation was shown to be useful for removing possible inhibitor(s) of viral specific hemagglutinin.
用鱼精蛋白处理1型登革热感染的小鼠脑悬液会导致几种病毒特异性活性沉淀。补体结合活性几乎完全被鱼精蛋白沉淀。沉淀中回收的补体结合成分在同源和异源反应中与未沉淀的参考登革热1抗原相当。登革热血凝素也通过相同处理沉淀。通过浮力密度离心将沉淀的血凝素分解为三个成分,其密度分别为1.236、1.215和1.178 g/ml。在未用鱼精蛋白处理的病毒制剂中检测到三个类似HA成分。在这两种情况下,效价最高的HA部分的浮力密度为1.21 - 1.22 g/ml。这些HA成分在血凝抑制反应中进行了测试,并被证明是病毒特异性的。已证明氯化铯密度梯度离心可用于去除病毒特异性血凝素的可能抑制剂。